The hypoglycaemic effect of pumpkins as anti-diabetic and functional medicines

Food Research International

Volumn 44, Issue 4, 2011, Pages 862-867

  Adams, Gary G ^a   Imran, Shahwar ^a   Wang, Sheng ^a   Mohammad, Abubaker ^a   Kok, Samil ^b   Gray, David A ^a   Channell, Guy A ^a   Morris, Gordon A ^a   Harding, Stephen E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

Anti diabetic; Diabetes; Functional medicine; Hypoglycaemia; Pumpkins

Indexed keywords

ANTI-DIABETIC; DIABETES; FUNCTIONAL MEDICINE; HYPOGLYCAEMIA; PUMPKINS;

MEDICAL PROBLEMS;

ANIMALIA; CUCURBITA;

EID: 79955577213     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2011.03.016     Document Type: Review

References (52)

1. Adolfo A.C., Michael H. Mexican plants with hypoglycaemic effect used in the treatment of diabetes. Journal of Ethnopharmacology 2005, 99:325-348.
2. Alberti K.G.M.M., Zimmet P., Shaw J. Metabolic syndrome-A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetes Medicine 2006, 23:469-480.
3. Appendino G., Jakupovic J., Belloro E., Marchesini A. Multiflorane triterpenoid esters from pumpkin. An unexpected extrafolic source of PABA. Phytochemistry 1999, 51:1021-1026.
4. Arredondo A., Zuniga A. Economic consequences of epidemiological changes in diadetes in middle-income countries. Diabetes Care 2004, 27:104-109.
5. AMERCIAN DIABETES ASSOCIATION (ADA) Diagnosis and classification of diabetes mellitus. Diabetes Care 2007, 30:S42-S47.
6. AMERCIAN DIABETES ASSOCIATION (ADA) Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008, 31:596-615.
7. AMERCIAN DIABETES ASSOCIATION (ADA) Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 30:S62-S69.
8. Atkinson M.A., Eisenbarth G.S. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 2001, 358:221-229.
9. Bang M.H., Han J.T., Kim H.Y., Park Y.D., Park C.H., Lee K.R., et al. 13-Hydroxy-9Z, 11E, 15E-octadecatrienoic acid from the leaves of Cucurbita moschata. Archives of Pharmacal Research 2002, 25(4):438-440.
10. Bonner-Weir S., Weir G.C. New sources of pancreatic β-cells. Nature Biotechnology 2005, 23:857-861.
11. Cai T., Li Q., Yan H., Li N. Study on the hypoglycemic action of pumpkin seed protein. Journal of Chinese Institute of Food Science and Technology 2003, 3(1):7-11.
12. Cockram C. The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Medical Journal 2000, 6:43-52.
13. Cryer P.E., Davis S.N., Shamoon H.S. Hypoglycemia in diabetes. Diabetes Care 2003, 26:1902-1912.
14. Diaz Obregon, Lloja D., Lozano L., Carbajal Zuniga V. Preclinical studies of Cucurbita maxima (pumpkin seeds) a traditional intestinal antiparasitic in rural urban areas. Revista de Gastroenterología del Perú 2004, 24(4):323-327.
15. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 26 Suppl 1:S5-20.
16. Fissore E.N., Ponce N.M., Stortz C.A., Rojas A.M., Gerschenson L.N. Characterisation of fibre obtained from pumpkin (Cucumis moschata duch.) mesocarp through enzymatic treatment. Food Science and Technology International 2007, 13:141-151.
17. Fowler M.J. Diagnosis, classification, and lifestyle treatment of diabetes. Clinical Diabetes 2010, 28:79-86.
18. Fu C.T.H., Cai T., Liu Y., Li Q. Some properties of an acidic protein-bound polysaccharide from the fruit of pumpkin. Food Chemistry 2007, 100:944-947.
19. Fu C., Shi H., Li Q. A review on pharmacological activites and utilization technologies of pumpkin. Plant Foods for Human Nutrition 2006, 61:73-80.
20. Gavin J.R., Alberti K.G.M.M., Davidson, Mayer B., DeFronzo R.A., Drash A., et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997, 20:1183-1197.
21. Gregg E.W., Beckles G.L., Williamson D.F., Leveille S.G., Langlois J.A., Engelgau M.M., et al. Diabetes and physical disability among older U.S. adults. Diabetes Care 2000, 23:1272-1277.
22. Gu M., Li D. Pumpkin hypoglycaemic active ingredients progress in pharmacological research. Journal of Medical Research 2008, 37(5):15-16.
23. Guillon F., Champ M. Structural and physical properties of dietary fibres, and consequences of processing on human physiology. Food Research International 2000, 33:233-245.
24. Hammer K.A., Carson C.F., Riley T.V. Antimicrobial activity of essential oils and other plant extracts. Journal of Applied Microbiology 1999, 86(6):985-990.
25. Hunt L.M., Arar N.H., Akana L.L. Herbs, prayer, and insulin: Use of medical and alternative treatments by a group of Mexican American diabetes patients. The Journal of Family Practice 2000, 49:216-223.
26. Imagawa A., Hanafusa T., Miyagawa J., Matsuzawa Y. A novel subtype pf type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. The New England Journal of Medicine 2000, 342:301-307.
27. Ito Y., Maeda S., Sugiyama T. Suppression of 7, 12-dimethylbenz[a]anthracene-induced chromosome aberrations in rat bone marrow cells by vegetable juices. Mutation Research 1986, 172(1):55-60.
28. Jia W., Gao W., Tang L. Antidabetic herbal drugs officially approved in China. Phytotherpapy Research 2003, 17:1127-1134.
29. Ju L., Chang D. Hypoglycemic effect of pumpkin powder. Journal of Harbin Medicine 2001, 21(1):5-6.
30. Kahn S.E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology. Diabeteologia 2003, 46:3-19.
31. Koike K., Li W., Liu L., Hata E., Nikaido T. New phenolic glycosides from the seeds of Cucurbita moschata. Chemical & Pharmaceutical Bulletin 2005, 53(2):225-228.
32. Kong Q.S. Studies on extraction and hypolipidemic activity of polysaccharides from pumpkin. Chin J Biochem Pharmaceu 2000, 21(3):7-11.
33. Kuhlmann H., Koetter U., Theurer C. Sterol contents in medicinal pumpkin (Cucurbita pepo convar. citrullinina var. styriaca) depending on genotype and location. Acta Horticulturae 1999, 492:175-178.
34. Li X., Fan W., Liu Z., Yang P., Shen J. The change of major nutrient component during fruit development of pumpkin (Cucurbita spp.). Journal of Northwest Science Technology University of Agriculture and Forest 2006, 34(7):111-115.
35. Li Q., Fu C., Rui Y., Hu G., Cai T. Effects of protein-bound polysaccharide isolated from pumpkin on insulin in diabetic rats. Plant Foods for Human Nutrition 2005, 60:1-4.
36. Raslova K. An update on the treatment of type 1 and type 2 diabetes mellitus: focus on the insulin detemir, a long-acting human insulin analog. Vascular Health and Risk Management 2010, 6:399-410.
37. Rendell M.S., Kirchain W.R. Pharmacotherapy of type 2 diabetes mellitus. The Annals of Pharmacotherapy 2000, 34(7):878-895.
38. Riccardi G.G.R., Parillo M., Turco S., Rivellese A.A., Ventura M.R., Contadini S., et al. Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: A placebo-controlled, double-blind, multicentre study. Diabetic Medicine 1999, 16:228-232.
39. Saganuwan A.S. Tropical plants with antihypertensive, antiasthmatic, and antidiabeteic value. Journal of Herbs, Spices &Medicinal Plants 2009, 15:24-44.
40. Shan J., Ren F., Tian G. Structure characterization and hypoglycemic activity of a glococonjugate from atractylodes macrocephalae koidz. Functional Plant Science and Biotechnology 2009, 3(1):36-41.
41. Shi Y., Xiong X., Cao J., Kang M. Effect of pumpkin polysaccharide granules on glycemic control in type 2 diabetes. Central South Pharmacy 2003, 1(5):275-276.
42. Simpson R.W., Shaw J.E., Zimmet P.Z. The prevention of type 2 diabetes: lifestyle change or pharmacotherapy? A challenge for the 21st century. Diabetes Research and Clinical Practice 2003, 59(3):165-180.
43. Smyth S., Heron A. Diabetes and obesity: The twin epidemics. Nature Medicine 2005, 12:75-80.
44. Tong H., Liang Z., Wang G. Structural characterization and hypoglycaemic activity of a polysaccharide isolated from the fruit of Physalis alkekengi L. Carbohydrate Polymers 2008, 71:316-323.
45. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
46. Xie J.M. Induced polarization effect of pumpkin protein on B16 cell. Fujian Med Univ Acta 2004, 38(4):394-395.
47. Xiong X., Cao J. Study of extraction and isolation of effective pumpkin polysaccharide component and its reducing glycemia function. Chinese J Modern Application Pharmacy 2001, 18:662-664.
48. Xu G.H. A study of the possible antitumour effect and immunocompetence of pumpkin polysaccharide. J Wuhan Prof Med Coll 2000, 28(4):1-4.
49. Yoshinari O., Sato H., Igarashi K. Anti-diabetic effects of pumpkin and its components, trigonelline and nicotinic acid, on Goto-Kakizaki rats. Bioscience, Biotechnology, and Biochemistry 2009, 73(5):1033-1041.
50. Zhang Y.J. Study on the hypoglycemic effects and extraction and analysis of pumpkin polysaccharide. Journal of China Jiliang University 2004, 15(3):238-241.
51. Zhang Y., Wang L., Yao H. Study on the biological effects and extraction of blood glucose lowering active component from pumpkin. Food and Fermentation Industries 2002, 28(6):32-35.
52. Zhang Y., Yao H. Study on effect of hypoglycemia of different type pumpkin. Journal of Chinese Food Science 2002, 23:118-120.